23andMe Can Now Tell You How You May Respond to Some Drugs. But Experts Are Wary
Consumer genetics company 23andMe on Wednesday became the first to secure Food and Drug Administration (FDA) approval for a report that provides information about how a person’s genetics may impact the efficacy of certain drugs. The approval, which comes with certain caveats and safety controls, expands the company’s ability to offer medical insights to customers — but some experts say that information should be approached with caution. This is the latest consumer advance in pharmacogenetics, or the study of how a person’s genes may alter the effects of certain drugs, including blood thinners and an...
Source: TIME: Health - November 1, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Genetics healthytime Source Type: news

Breast cancer mutation increases interval cancer risk
Women who carry a certain rare breast cancer mutation are more likely to develop...Read more on AuntMinnie.comRelated Reading: Dense breast tissue translates into higher cancer odds Age, not density, predicts interval breast cancer result Automated breast density assessment informs cancer risk Visual aid pinpoints women at high risk of breast cancer Set your breast clinic apart with risk-based resources (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 1, 2018 Category: Radiology Source Type: news

Race may impact help-seeking by women facing barriers to breast cancer care
(Reuters Health) - African American women with abnormal mammograms may be less likely than those from other ethnic and racial groups to recognize the barriers to follow-up care that can delay a breast cancer diagnosis or to seek help overcoming them, a U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - November 1, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Kenya:Cancer Warrior - a Bundle of Joy in the Middle of Gloom
[Nation] Lucky Ndanu was only 23 when she was diagnosed with breast cancer. The 33-year-old cancer warrior, mother, data analyst and project manager talks to Nation.co.ke about her journey. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 1, 2018 Category: African Health Source Type: news

Africa:Early Detection Vital to Treating Breast Cancer
[CAJ News] Johannesburg -SOUTH African women have been encouraged to have their breast health monitored regularly in order to detect breast cancer at an early stage. At that stage, treatment has the best chance of success. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 1, 2018 Category: African Health Source Type: news

Nigeria:Lagoon Hospitals Engage Residents On Awareness Walk to Prevent Breast Cancer
[Guardian] In its bid to reduce the scourge of cancer in Nigeria, Lagoon hospitals, at the weekend, engaged residents of Victoria Island, Lagos on a breast cancer awareness walk on early detection, treatment, and the need for a reliable, permanent cure. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 1, 2018 Category: African Health Source Type: news

Women carrying rare breast cancer variants more likely to develop interval breast cancers
(American Association for Cancer Research) While the presence of common breast cancer mutations was indicative of increased breast cancer risk, the presence of certain rare mutations was indicative of increased risk from interval breast cancers and death. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 1, 2018 Category: International Medicine & Public Health Source Type: news

Clinical pathway programme high-value care in breast cancer
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2018 Category: Drugs & Pharmacology Source Type: news

Genetic Risk Score IDs Breast CA Risk in Female Child CA Survivors
Survivors in highest quintile of polygenic risk score have increased relative rate of breast cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 31, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Journal, Source Type: news

First PI3K Inhibitor to Improve Outcomes in HR+/HER2 − Breast Cancer
The SOLAR-1 trial tested whether the PI3K inhibitor alpelisib improved outcomes in HR+, HER2 − breast cancer patients. (Source: CancerNetwork)
Source: CancerNetwork - October 31, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Researchers identify patients facing greatest risk of cancer's return
St. Jude researchers believe gene variations could help identify pediatric cancer survivors who are especially likely to face a breast cancer diagnosis later in life. The findings of a new St. Jude Children’s Research Hospital study determined that childhood cancer survivors with a specific combination of genetic variations are at a much higher risk of breast cancer compared to other survivors of pediatric cancers. Researchers found the combined effect of th e 170 common gene variations is comparable… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 31, 2018 Category: American Health Authors: Caitlin Mullen Source Type: news

Male Breast Cancer: Current Clinical Practice'Justified'Male Breast Cancer: Current Clinical Practice'Justified '
Despite differences in demographic and disease-related characteristics, male breast cancer patients are treated similarly to female patients, with similar outcomes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 31, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Genetic Risk Score IDs Breast CA Risk in Female Child CA Survivors
WEDNESDAY, Oct. 31, 2018 -- A polygenic risk score (PRS) can identify subsequent breast cancer risk among childhood survivors of cancer, according to a study published online Oct. 26 in Clinical Cancer Research. Zhaoming Wang, Ph.D., from St. Jude... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 31, 2018 Category: Pharmaceuticals Source Type: news

Sex hormone blocker increases likelihood of pregnancy in breast cancer patients
The sex hormone blocker, goserelin, protects the ovaries from breast cancer chemotherapy, improving the likelihood of future pregnancy, according to research published in theJournal of the National Cancer Institute. Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 31, 2018 Category: Endocrinology Source Type: news

Boosting confidence after breast cancer in Salisbury
This case study illustrates how cancer survivors in Salisbury feel more confident and less fatigued after enhanced support to live better after cancer. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 31, 2018 Category: Consumer Health News Source Type: news

Dermoscopy of Skin Metastases From Breast Cancer Dermoscopy of Skin Metastases From Breast Cancer
This report highlights the utility of dermoscopy for accurate diagnosis of cutaneous metastatic breast cancer, describing dermoscopic patterns of the disease.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 31, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Social media could help raise breast screening take-up
First-time attendances rose by 13% in Stoke-on-Trent after project through Facebook groups Related items fromOnMedica NICE rejects breast cancer drug for NHS funding Women who lost weight had lower breast cancer risk NICE rejects adjuvant use of breast cancer drug Cancer diagnosis via screening offers best outcomes (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 31, 2018 Category: UK Health Source Type: news

New Method Estimates Risk for Recurrence in Breast Cancer
Higher recurrence risk linked to older age, more advanced stage, HR - negative tumors (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 30, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Journal, Source Type: news

Another Analysis of Trastuzumab for Only 9 Weeks: Not an Option Another Analysis of Trastuzumab for Only 9 Weeks: Not an Option
A 9-week course of trastuzumab for low- and intermediate-risk early breast cancer looks possible but is not recommended as a standard of care according to experts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 30, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

#DYK: Mammograms are still the best tool for breast cancer screening. Check out @US_FDA ’ s information on the importance of choosing a certified mammography facility: https://go.usa.gov/xPPpT   #MedicalDevice #BreastCancerAwarenessMonthpic.twitter.com/YaGqeGgrTH
#DYK: Mammograms are still the best tool for breast cancer screening. Check out @US_FDA’s information on the importance of choosing a certified mammography facility: https://go.usa.gov/xPPpT  #MedicalDevice #BreastCancerAwarenessMonth pic.twitter.com/YaGqeGgrTH (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - October 30, 2018 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

New Method Estimates Risk for Recurrence in Breast Cancer
TUESDAY, Oct. 30, 2018 -- The risk for breast cancer recurrence can be extracted using disease-specific survival data, according to a study published online Oct. 18 in Cancer Epidemiology, Biomarkers& Prevention. Angela B. Mariotto, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 30, 2018 Category: Pharmaceuticals Source Type: news

UC researchers developing test for early breast lesions
(University of Cincinnati Academic Health Center) Researchers at the University of Cincinnati (UC) are investigating a molecular diagnostic test to determine whether, after biopsy, someone is at high or low risk for actually developing malignant breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 30, 2018 Category: Cancer & Oncology Source Type: news

City of Hope opens CAR T trial for HER2 breast cancer patients with brain metastases
(City of Hope) Women with HER2-positive breast cancer that has spread to the brain need more treatment options, and City of Hope and Mustang Bio Inc. are meeting that challenge. A new City of Hope chimeric antigen receptor (CAR) T cell trial -- the first to focus on HER2-postive breast cancer patients with brain metastases -- is now enrolling potential participants. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 30, 2018 Category: International Medicine & Public Health Source Type: news

'I never knew men could get breast cancer'
Moses Musonga, a 67-year-old Kenyan, got a shock when he was diagnosed with the disease. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 30, 2018 Category: Consumer Health News Source Type: news

Mayo Clinic Minute: Can you prevent breast cancer?
Breast cancer is the most common cancer in women, according to the Centers for Disease Control and Prevention. Dr. Karthik Ghosh says, no matter what your personal risk is, there are ways that may help lower your chances of getting the disease. https://youtu.be/H_RpoHB-jYM Watch: The Mayo Clinic Minute Journalists: Broadcast-quality video pkg (0:59) is in [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 30, 2018 Category: Databases & Libraries Source Type: news

FDA committed to studying breast implant safety
By Dr. Binita Ashar, director of the division of surgical devices in the FDA’s Center for Devices and Radiological Health Choosing to obtain a breast implant, whether for augmentation or reconstruction, is a deeply personal choice, from the initial decision to undergo breast implant surgery to the size, material and surface texture. These types of decisions should be discussed between a patient and their provider in a transparent and balanced way with clear information about the benefits and risks of the breast implants and the procedure. As a public health agency, we play an important role in ensuring that patients ...
Source: Mass Device - October 29, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog FDA Voice Source Type: news

DBT doesn't hurt screening throughput
Implementing digital breast tomosynthesis (DBT) at a breast center doesn't...Read more on AuntMinnie.comRelated Reading: DBT spots 34% more breast cancers than mammography DBT plus ABVS offers a breast cancer staging alternative Synthesized 2D similar to FFDM for finding microcalcs Breast MRI works for evaluating equivocal DBT findings Could DBT change the equation of screening younger women? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 29, 2018 Category: Radiology Source Type: news

Radiation therapy cuts low risk of recurrence by nearly 3/4 for patients with 'good risk'
(American Society for Radiation Oncology) A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiation therapy, finds a new long-term clinical trial report. These 12-year follow-up data from the only prospective, randomized trial to compare recurrence outcomes after treatment for low-risk ductal carcinoma in situ (DCIS) were presented last week at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 29, 2018 Category: Cancer & Oncology Source Type: news

Long-term side effects similarly low for weekly, conventional breast radiation, trial finds
(American Society for Radiation Oncology) In a 10-year study of women who received radiation therapy to treat early-stage breast cancer, those receiving fewer, larger individual doses experienced similarly low rates of late-onset side effects as those undergoing conventional radiation therapy. Findings from the multi-institutional U.K. FAST clinical trial were presented last week at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 29, 2018 Category: Cancer & Oncology Source Type: news

Hormone-blocking injections reduce early menopause from breast cancer treatment
(SWOG) Final results of SWOG Cancer Research Network's groundbreaking international Prevention of Early Menopause Study (POEMS) clinical trial are in, and they show continued evidence that women who get injections of the hormone drug goserelin along with standard breast cancer chemotherapy are more likely to become pregnant - without developing negative side effects or shortening their lives. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 29, 2018 Category: International Medicine & Public Health Source Type: news

Science Saturday: Finding and treating breast cancer sooner
October is Breast Cancer Awareness Month, a time to reflect on new, individualized approaches to detecting and treating a cancer that affects 1 in 8 American women. Deborah Rhodes, M.D. and her Mayo Clinic colleagues are working to identify the best targeted screening tools and guidelines for women with a higher risk of developing breast [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 27, 2018 Category: Databases & Libraries Source Type: news

Could Low-Risk Breast Cancer Patients Benefit From Shorter Trastuzumab Treatment?
A subgroup analysis of Short-HER looked at the differences in 5-year DFS rates for 9 weeks vs 1 year of trastuzumab for HER2+ breast cancer patients. (Source: CancerNetwork)
Source: CancerNetwork - October 26, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Woman who live-streamed breast cancer surgery shares message for others
50-year-old Sonia Johnson offered an inside look from the operating room for about 27 minutes (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 26, 2018 Category: Consumer Health News Source Type: news

Philips launches all-in-one breast ultrasound system
Royal Philips (NYSE:PHG) said yesterday it launched an all-in-one breast assessment solution designed for use with its Epiq and Affiniti ultrasound systems. The newly launched solution, which has received CE Mark approval in the European Union and FDA 510(k) clearance in the US, is intended for the assessment, monitoring and treatment of breast diseases, the Amsterdam-based company said. “Ultrasound plays an increasingly important role in breast cancer screening and assessment, helping to detect lesions that mammography alone may not find. Philips is committed to developing the tools clinicians need to deliver t...
Source: Mass Device - October 26, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Ultrasound Women's Health royalphilips Source Type: news

New Model to Estimate Time to Metastasis in Breast Cancer New Model to Estimate Time to Metastasis in Breast Cancer
A novel method helps estimate the risk for disease progression for women with early breast cancer and may apply to other tumor types.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 26, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Men can also be diagnosed with breast cancer. Check out the @US_FDA ’ s information regarding breast cancer in men, available treatments and counseling options: https://go.usa.gov/xPPpx   ) #MedicalDevice #BreastCancerAwarenessMonthpic.twitter.com/aZBjgCGsB1
Men can also be diagnosed with breast cancer. Check out the @US_FDA’s information regarding breast cancer in men, available treatments and counseling options: https://go.usa.gov/xPPpx  ) #MedicalDevice #BreastCancerAwarenessMonth pic.twitter.com/aZBjgCGsB1 (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - October 26, 2018 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

Woman who live-streamed breast cancer surgery saw opportunity to "pay it forward"
Around one in eight American women will develop breast cancer in their lifetime. Texas doctors performed breast cancer surgery Thursday on 50-year-old Sonia Johnson. She broadcasted her surgery live on the hospital's Facebook page to raise awareness. Sonia and her surgeon, Dr. Allison DiPasquale, join "CBS This Morning" from Dallas to discuss the surgery. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 26, 2018 Category: Consumer Health News Source Type: news

Breast-Feeding Is Good for the Mother, and Not Just the Baby
Women who breast-feed are less likely to develop breast cancer, ovarian cancer, Type 2 diabetes and rheumatoid arthritis and may have improved cardiovascular health. (Source: NYT Health)
Source: NYT Health - October 26, 2018 Category: Consumer Health News Authors: RONI CARYN RABIN Tags: Breast Cancer Breastfeeding Women and Girls Ovarian Cancer Pregnancy and Childbirth Diabetes Babies and Infants Parenting Infant Formulas Source Type: news

Genetic profiling may inform breast cancer risk in young childhood cancer survivors
(American Association for Cancer Research) A combined evaluation of common variants with small effects and rare predisposing mutations among young female childhood cancer survivors may further stratify this high-risk population for subsequent breast cancer risk. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 26, 2018 Category: Cancer & Oncology Source Type: news

Small risks may have big impact on breast cancer odds of childhood cancer survivors
(St. Jude Children's Research Hospital) St. Jude Children's Research Hospital scientists found that the combined effect of common genetic variations can dramatically increase risk of breast cancer for female pediatric cancer survivors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 26, 2018 Category: Cancer & Oncology Source Type: news

Biosimilars: New Avenues for the Practicing Oncologist Treating Breast Cancer
Research presented this week at ESMO studied the efficacy of  biosimilars to trastuzumab compared with the reference product in breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - October 26, 2018 Category: Cancer & Oncology Authors: Traci DeVito Source Type: news

Living With Cancer: Understanding male breast cancer
Male breast cancer? Male breast cancer is rare. It's most common in older men, though it can occur at any age. Men diagnosed with breast cancer at an early stage have a good chance for a cure. Your health care provider will consider the stage of your cancer, and your overall health and preferences when [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 26, 2018 Category: Databases & Libraries Source Type: news

Thousands watch woman's breast cancer surgery on Facebook
After a routine screening, Sonia Johnson was diagnosed with breast cancer. She was told she needed surgery to remove the tumor, so she decided to livestream the process on Facebook. CBS News medical contributor Dr. Tara Narula explains. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 25, 2018 Category: Consumer Health News Source Type: news

Texas woman livestreams breast cancer surgery to 26,000 Facebook users
Sonia Johnson of Texas was diagnosed with breast cancer last December. In honor of breast cancer awareness month and in the hopes others will get checked, she streamed her lumpectomy today. (Source: the Mail online | Health)
Source: the Mail online | Health - October 25, 2018 Category: Consumer Health News Source Type: news

Woman has breast cancer surgery on Facebook Live
"This morning I was saying I have cancer. Now I can say I had cancer," she said after the live-streamed operation (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 25, 2018 Category: Consumer Health News Source Type: news

Where breast cancer research fits in Birmingham's commercialization push
Birmingham ’s research institutions are making a play for more commercialization – and breast cancer is a potential target. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - October 25, 2018 Category: Health Management Authors: Tyler Patchen Source Type: news

Survival Bump with Palbociclib in HR+ Breast Cancer
(MedPage Today) -- But benefit limited to subgroups; study may have been underpowered (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - October 25, 2018 Category: Primary Care Source Type: news

Researchers develop nanodevice to deliver immunotherapy
Image credit: Houston Methodist Researchers at Houston Methodist Research Institute have created a nanodevice that can be used to deliver immunotherapy to treat triple-negative breast cancer. The tiny device is designed to be inserted directly into a tumor, delivering a localized, sustained-release dose of therapy and eliminating the need for patients to undergo IV treatments. Get the full story at our sister site, Drug Delivery Business News. The post Researchers develop nanodevice to deliver immunotherapy appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - October 25, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Featured Oncology Pharmaceuticals Research & Development Source Type: news

Woman having breast cancer surgery on Facebook Live
"Right now I say I have cancer. Tomorrow I will say 'I had cancer'," she said before the live-streamed operation (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 25, 2018 Category: Consumer Health News Source Type: news

Weight Loss and Breast Cancer Risk After Menopause Weight Loss and Breast Cancer Risk After Menopause
Good news for women: Even modest weight loss can reduce risk for postmenopausal breast cancer.Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 25, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news